{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-029839","form_type":"8-K","ticker":"PURE","cik":"0001006028","company_name":"PURE BIOSCIENCE, INC.","filed_at":"2022-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.191672+00:00","generated_at":"2026-06-22T22:17:10.147764+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PURE Bioscience FY2022 revenue down 51% to $1.8M; net loss widens to $3.5M","bullets":["Net product sales of $1.81M vs $3.70M in FY2021; royalties fell to $40K from $229K.","Net loss of $3.5M ($0.04/sh) compared to $2.3M ($0.03/sh) in prior year.","Net loss excluding stock compensation was $2.9M; cash used in operations $2.5M.","Sales team expanded: three street execs, Midwest manager, two AVP corporate accounts.","CRM software implemented; two-team sales approach targeting janitorial and sanitation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-029839","json":"https://secwatch.observer/filing/0001493152-22-029839.json","markdown":"https://secwatch.observer/filing/0001493152-22-029839.md","text":"https://secwatch.observer/filing/0001493152-22-029839.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006028/000149315222029839/0001493152-22-029839-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006028/000149315222029839/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T22:17:10.147764+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"04054f4aa7f1f4fe3e97bde9ada43ac35df882c3","claim":"PURE BIOSCIENCE, INC. reported fiscal year ended July 31, 2022 results: revenue $1,813,000, net income ($3.5 million), EPS ($0.04).","evidence_excerpt":"● Net product sales were $1,813,000 and $3,698,000 for the fiscal years ended July 31, 2022 and 2021, respectively. The decrease of $1,885,000 was attributable to decreased sales across our distribution and end-user network servicing the food processing, transportation, and janitorial industries. In addition, during the fiscal year ended July 31, 2022, we recognized $40,000 in royalties, compared to $229,000 in royalties for the fiscal year ended July 31, 2021. ● Net loss for the fiscal year ended July 31, 2022 was ($3.5 million), compared to ($2.3 million) for the fiscal year ended July 31, 2021. ● Net loss, excluding share-based compensation, for the fiscal year ended July 31, 2022 was ($2.9 million), compared to ($1.3 million) for the fiscal year ended July 31, 2021. ● Net loss per share was ($0.04) for the fiscal year ended July 31, 2022, compared to ($0.03) per share for the fiscal year ended July 31, 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315222029839/0001493152-22-029839-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended July 31, 2022"},{"label":"Revenue","value":"$1,813,000"},{"label":"Net income","value":"($3.5 million)"},{"label":"EPS","value":"($0.04)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}